Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEAR Men B: 4CMenB Schedules in Preterm Infants
NCT03125616Phase 4Completed
- Sponsor
- St George's, University of London
- Start
- Aug 2017
- Primary completion
- Sep 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of meningococcal group B vaccine in meningococcal group B infection (MenB), sponsored by St George's, University of London. Started Aug 2017; status: completed.
02
Drugs
meningococcal group B vaccine
03
Conditions
meningococcal group B infection (MenB)
Beyond the preview
Go deeper on NCT03125616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03125616.